Matches in Nanopublications for { ?s ?p "northera is indicated for the treatment of orthostatic dizziness lightheadedness or the feeling that you are about to black out in adult patients with symptomatic neurogenic orthostatic hypotension noh caused by primary autonomic failure parkinson s disease pd multiple system atrophy and pure autonomic failure dopamine beta hydroxylase deficiency and non diabetic autonomic neuropathy effectiveness beyond 2 weeks of treatment has not been established the continued effectiveness of northera should be assessed periodically northera is indicated for the treatment of orthostatic dizziness lightheadedness or the feeling that you are about to black out in adult patients with symptomatic neurogenic orthostatic hypotension noh caused by primary autonomic failure parkinson s disease pd multiple system atrophy and pure autonomic failure dopamine beta hydroxylase deficiency and non diabetic autonomic neuropathy effectiveness beyond 2 weeks of treatment has not been established the continued effectiveness of northera should be assessed periodically 1" ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- association label "northera is indicated for the treatment of orthostatic dizziness lightheadedness or the feeling that you are about to black out in adult patients with symptomatic neurogenic orthostatic hypotension noh caused by primary autonomic failure parkinson s disease pd multiple system atrophy and pure autonomic failure dopamine beta hydroxylase deficiency and non diabetic autonomic neuropathy effectiveness beyond 2 weeks of treatment has not been established the continued effectiveness of northera should be assessed periodically northera is indicated for the treatment of orthostatic dizziness lightheadedness or the feeling that you are about to black out in adult patients with symptomatic neurogenic orthostatic hypotension noh caused by primary autonomic failure parkinson s disease pd multiple system atrophy and pure autonomic failure dopamine beta hydroxylase deficiency and non diabetic autonomic neuropathy effectiveness beyond 2 weeks of treatment has not been established the continued effectiveness of northera should be assessed periodically 1" assertion.